Showing results (701-710 of 963) with videos related to

Sort By:
Pageof 97
Gastroenterology|December 26, 2013
Randomized comparison of tenofovir disoproxil fumarate vs emtricitabine and tenofovir disoproxil fumarate in patients with lamivudine-resistant chronic hepatitis BScott Fung, Peter Kwan, Milotka Fabri, et al.
Alimentary Pharmacology & Therapeutics|October 13, 2017
HBeAg levels at week 24 predict response to 8 years of tenofovir in HBeAg-positive chronic hepatitis B patientsD Wong, M Littlejohn, L Yuen, et al.
Frontiers in Microbiology|February 21, 2022
Metagenomics Versus Metatranscriptomics of the Murine Gut Microbiome for Assessing Microbial Metabolism During InflammationJuan Jovel, Aissata Nimaga, Tracy Jordan, et al.
Journal of Viral Hepatitis|May 9, 2020
HBV variants are common in the 'immune-tolerant' phase of chronic hepatitis BLilly Yuen, Peter A Revill, Gillian Rosenberg, et al.
Journal of Viral Hepatitis|March 16, 2017
Effect of viral suppression on hepatic venous pressure gradient in hepatitis C with cirrhosis and portal hypertensionN Afdhal, G T Everson, J L Calleja, et al.
Gastroenterology|January 18, 2012
Effect of IL28B genotype on early viral kinetics during interferon-free treatment of patients with chronic hepatitis CTom W Chu, Rohit Kulkarni, Edward J Gane, et al.
Journal of Hepatology|August 26, 2014
Telbivudine plus pegylated interferon alfa-2a in a randomized study in chronic hepatitis B is associated with an unexpected high rate of peripheral neuropathyPatrick Marcellin, Karsten Wursthorn, Heiner Wedemeyer, et al.
Hepatology International|March 20, 2015
Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 yearsMaria Buti, Scott Fung, Edward Gane, et al.
Nature Communications|June 16, 2018
Quantitative in vivo whole genome motility screen reveals novel therapeutic targets to block cancer metastasisKonstantin Stoletov, Lian Willetts, Robert J Paproski, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 25, 2019
Outcomes of Treatment for Hepatitis C in Primary Care, Compared to Hospital-based Care: A Randomized, Controlled Trial in People Who Inject DrugsAmanda J Wade, Joseph S Doyle, Edward Gane, et al.
Pageof 97